Skip to main content
CI
NYSE Finance

Cigna Q3 Adjusted EPS $7.98, Raises 2026 Outlook to at Least $30.60

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$307.26
Mkt Cap
$80.702B
52W Low
$255.528
52W High
$316.265
52W Position info
20% above low
Off High info
2.8% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CI sits 20% above its 52-week low of $255.528.

Summary

Cigna reported Q3 2026 adjusted EPS of $7.98 on $73.7 billion of revenue and raised full-year adjusted earnings guidance to at least $30.60 per share. Pharmacy benefit profit fell 22% on client contract renewals while medical membership grew 2%.


Key Events · Earnings and Guidance · CI

  • Q3 Adjusted EPS $7.98, Revenue $73.7B

    Adjusted income from operations was $2.1 billion, or $7.98 per share, versus $7.83 a year ago. Total revenues rose 6% to $73.7 billion from $69.7 billion.

  • 2026 Outlook Raised to at Least $30.60

    Full-year adjusted income from operations guidance moves up $0.15 per share to at least $30.60. Cigna Healthcare pre-tax target rises $50 million to at least $4,600 million and the medical care ratio range narrows by 50 bps to 84.2% +/- 25 bps.

  • Pharmacy Benefit Profit Down 22%

    Evernorth pre-tax adjusted income fell 4% to $1,829 million as Pharmacy Benefit Services dropped 22% to $765 million on large client contract renewals and strategic investments. Specialty and Care Services rose 15% to $1,064 million.

  • Customer Relationships Down 6%

    Total customer relationships were 177.6 million at September 30, 2026, down 6% from December 31, 2025. Behavioral customers fell 19% to 23 million after a government contract termination; total medical customers rose 2% to 18.5 million.


Analysis · CI · Finance

Cigna's third quarter came in roughly flat on adjusted earnings, but the company nudged full-year guidance higher, to at least $30.60 per share from at least $30.45, and lifted the Cigna Healthcare segment target by $50 million while narrowing the medical care ratio range by 50 basis points. Revenue grew 6% to $73.7 billion, with Evernorth up 6% and Cigna Healthcare up 9%. The soft spots are visible: Pharmacy Benefit Services pre-tax profit fell 22% on large client contract renewals, and total customer relationships dropped 6% from year-end to 177.6 million, including a 19% fall in behavioral customers after a government contract ended. For a company this size the guidance move is small in dollars, but it confirms the 2026 earnings base is intact heading into the ACA marketplace exit on January 1, 2027.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CI was trading at $307.26 on NYSE in the Finance sector, with a market capitalization of approximately $80.7B. The 52-week trading range was $255.53 to $316.27. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Nov 05, 2026, 1:00 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $302.34
Real-time Price: $271.65 info
Change: -$30.69 (-10%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 11:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $312.17
Real-time Price: $271.65 info
Change: -$40.52 (-13%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 6:51 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $271.65 info
Change: -$35.61 (-12%) info
Market Cap: $71.947B info
CI
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $300.90
Real-time Price: $271.65 info
Change: -$29.25 (-10%) info
Market Cap: $71.947B info
CI
Oct 01, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $271.83
Real-time Price: $271.65 info
Change: -$0.1825 (-0.07%) info
Market Cap: $71.947B info